Aandelen in “Gezondheidstechnologie”
| Aandeel | Datum | Koers | Evolutie |
|---|---|---|---|
Kala Pharmaceuticals Inc |
4/02 | 9,300 USD
+0,87% |
+0,87% |
|
Kaleido Biosciences Inc |
17/12 | 0,000 USD
0,00% |
0,00% |
|
KalVista Pharmaceuticals Inc |
4/02 | 9,750 USD
+5,75% |
+5,75% |
|
Kamada Ltd. |
4/02 | 6,900 USD
+2,07% |
+2,07% |
Kane Biotech Inc. |
4/02 | 0,110 CAD
+4,76% |
+4,76% |
|
Karyopharm Therapeutics Inc |
4/02 | 0,620 USD
-0,39% |
-0,39% |
|
Kazia Therapeutics Limited |
4/02 | 1,400 USD
-6,04% |
-6,04% |
|
Keros Therapeutics Inc |
4/02 | 11,000 USD
-1,17% |
-1,17% |
|
Kezar Life Sciences Inc |
4/02 | 6,240 USD
+0,32% |
+0,32% |
|
Kiniksa Pharmaceuticals Ltd |
4/02 | 18,740 USD
-0,74% |
-0,74% |
|
Kiromic BioPharma Inc |
4/02 | 1,170 USD
+50,58% |
+50,58% |
|
Knight Therapeutics Inc |
4/02 | 5,550 CAD
+1,65% |
+1,65% |
|
Kodiak Sciences Inc |
4/02 | 5,770 USD
-0,86% |
-0,86% |
|
Koninklijke Philips NV |
4/02 | 26,910 USD
+0,45% |
+0,45% |
|
Kronos Bio Inc |
4/02 | 0,991 USD
+1,22% |
+1,22% |
|
Krystal Biotech Inc |
4/02 | 161,300 USD
+1,43% |
+1,43% |
|
Kura Oncology Inc |
4/02 | 8,890 USD
+7,76% |
+7,76% |
|
Kymera Therapeutics Inc |
4/02 | 38,730 USD
+0,62% |
+0,62% |